Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, et al. BNP-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive heart failure (TIME-CHF) randomized trial. JAMA. 2009;301(4):383–92.

Article  CAS  PubMed  Google Scholar 

O’Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, et al. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med. 2011;365(1):32–43.

Article  CAS  PubMed  Google Scholar 

Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269–85.

Article  PubMed  Google Scholar 

Murphy SP, Kakkar R, McCarthy CP, Januzzi JL Jr. Inflammation in heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(11):1324–40.

Article  PubMed  Google Scholar 

Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL). Circulation. 2004;109(13):1594–602.

Article  CAS  PubMed  Google Scholar 

Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Anti TNFTACHFI: Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation. 2003;107(25):3133–40.

Article  CAS  PubMed  Google Scholar 

Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM. Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation. 2019;139(10):1289–99.

Article  CAS  PubMed  Google Scholar 

Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013;309(12):1268–77.

Article  CAS  PubMed  Google Scholar 

Tousoulis D, Papageorgiou N, Androulakis E, Briasoulis A, Antoniades C, Stefanadis C. Fibrinogen and cardiovascular disease: genetics and biomarkers. Blood Rev. 2011;25(6):239–45.

Article  CAS  PubMed  Google Scholar 

Barazzoni R, Zanetti M, Davanzo G, Kiwanuka E, Carraro P, Tiengo A, Tessari P. Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. J Clin Endocrinol Metab. 2000;85(9):3121–5.

Article  CAS  PubMed  Google Scholar 

Yuan D, Jiang P, Zhu P, Jia S, Zhang C, Liu Y, Liu R, Xu J, Tang X, Zhao X, et al. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study. Cardiovasc Diabetol. 2021;20(1):143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mitch WE. Malnutrition: a frequent misdiagnosis for hemodialysis patients. J Clin Invest. 2002;110(4):437–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–7.

Article  PubMed  Google Scholar 

Zhu H, Zhang W, Ye P, Wu M. Preoperative circulating fibrinogen to albumin ratio in predicting 5-year prognosis of oral cancer radical surgery. Neoplasma. 2022.

Yang Q, Liang D, Yu Y, Lv F. The prognostic significance of the fibrinogen-to-albumin ratio in patients with triple-negative breast cancer: a retrospective study. Front Surg. 2022;9:916298.

Article  PubMed  PubMed Central  Google Scholar 

Xu J, Li S, Feng Y, Zhang J, Peng Y, Wang X, Wang H. The fibrinogen/albumin ratio index as an independent prognostic biomarker for patients with combined hepatocellular cholangiocarcinoma after surgery. Cancer Manag Res. 2022;14:1795–806.

Article  PubMed  PubMed Central  Google Scholar 

Wu W, Wang Q, Han D, Li J, Nie Y, Guo D, Yang L, Tao K, Zhang X, Dou K. Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection. Cancer Cell Int. 2021;21(1):500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu Y, Tao S, Zhang D, Xiao J, Wang X, Yuan L, Pan H, Wang D. Association between fibrinogen/albumin ratio and severity of coronary artery calcification in patients with chronic kidney disease: a retrospective study. PeerJ. 2022;10:e13550.

Article  PubMed  PubMed Central  Google Scholar 

Celebi S, Ozcan Celebi O, Berkalp B, Amasyali B. The association between the fibrinogen-to-albumin ratio and coronary artery disease severity in patients with stable coronary artery disease. Coron Artery Dis. 2020;31(6):512–7.

Article  PubMed  Google Scholar 

Wang P, Yuan D, Zhang C, Zhu P, Jia S, Song Y, Tang X, Xu J, Li T, Zeng G, et al. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc Diabetol. 2022;21(1):46.

Article  PubMed  PubMed Central  Google Scholar 

Karahan O, Acet H, Ertas F, Tezcan O, Caliskan A, Demir M, Kaya AF, Demirtas S, Cevik MU, Yavuz C. The relationship between fibrinogen to albumin ratio and severity of coronary artery disease in patients with STEMI. Am J Emerg Med. 2016;34(6):1037–42.

Article  PubMed  Google Scholar 

Xiao L, Jia Y, Wang X, Huang H. The impact of preoperative fibrinogen-albumin ratio on mortality in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clin Chim Acta. 2019;493:8–13.

Article  CAS  PubMed  Google Scholar 

Odegaard AO, Jacobs DR Jr, Sanchez OA, Goff DC Jr, Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016;15:51.

Article  PubMed  PubMed Central  Google Scholar 

Kong MG, Jang SY, Jang J, Cho HJ, Lee S, Lee SE, Kim KH, Yoo BS, Kang SM, Baek SH, et al. Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study. Cardiovasc Diabetol. 2020;19(1):49.

Article  PubMed  PubMed Central  Google Scholar 

De Groote P, Lamblin N, Mouquet F, Plichon D, McFadden E, Van Belle E, Bauters C. Impact of diabetes mellitus on long-term survival in patients with congestive heart failure. Eur Heart J. 2004;25(8):656–62.

Article  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). With the special contribution of the heart failure association (HFA) of the ESC. G Ital Cardiol. 2022;23(4 Suppl 1):e1–127.

Google Scholar 

American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13–28.

Article  Google Scholar 

Li J, Zhou X, Xiang Y, Zhang S, Feng W, Yuan Y, Liu Y, Yin S. Clinical significance of preoperative fibrinogen to albumin ratio in patients with glioblastoma: a singe center experience. Cancer Manag Res. 2021;13:3259–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mai RY, Bai T, Luo XL, Wu GB. Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomy. BMC Gastroenterol. 2022;22(1):261.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu H, Qiu G, Hu F, Wu H. Fibrinogen/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection. World J Surg Oncol. 2021;19(1):218.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Xu W, Wang Y. Prognostic role of preoperative fibrinogen to albumin ratio in breast cancer. Clin Chim Acta. 2020;510:360–2.

Article  CAS  PubMed  Google Scholar 

Binti NN, Ferdausi N, Anik MEK, Islam LN. Association of albumin, fibrinogen, and modified proteins with acute coronary syndrome. PLoS ONE. 2022;17(7):e0271882.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duan Z, Luo C, Fu B, Han D. Association between fibrinogen-to-albumin ratio and the presence and severity of coronary artery disease in patients with acute coronary syndrome. BMC Cardiovasc Disord. 2021;21(1):588.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Erdogan G, Arslan U, Yenercag M, Durmus G, Tugrul S, Sahin I. Relationship between the fibrinogen-to-albumin ratio and syntax score in patients with non-ST-elevation myocardial infarction. Rev Invest Clin. 2021;10:11.

Google Scholar 

Li M, Tang C, Luo E, Qin Y, Wang D, Yan G. Relation of fibrinogen-to-albumin ratio to severity of coronary artery disease and long-term prognosis in patients with non-st elevation acute coronary syndrome. Biomed Res Int. 2020;2020:1860268.

PubMed  PubMed Central  Google Scholar 

Liu G, Fan CM, Guo H, Fan WN, Li ML, Cui GX. Fibrinogen-to-albumin ratio predicts long-term outcomes for patients with ST-elevation myocardial infarction and multivessel disease: a prospective observational cohort study. Exp Ther Med. 2021;21(5):465.